Investors

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
May 17, 2010 goldstein joseph l Director Sell 400 28.06
May 14, 2010 goldstein joseph l Director Option Execute 5,000 25.43
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
Aug 11, 2008 goldstein joseph l Director Acquisition (Non Open Market) 3,000 n/a
Jan 22, 2008 goldstein joseph l Director Option Execute 5,000 7.66
Jan 22, 2008 goldstein joseph l Director Automatic Sell 5,000 25.00
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Nov 5, 2007 goldstein joseph l Director Option Execute 4,200 7.66
Nov 5, 2007 goldstein joseph l Director Automatic Sell 4,200 20.38 - 20.63
Jun 3, 2010 kolinski stuart Officer Option Execute 12,500 8.50
Jun 3, 2010 kolinski stuart Officer Automatic Sell 6,784 30.02
Feb 3, 2010 kolinski stuart Officer Automatic Sell 5,401 27.66 - 28.08
Feb 2, 2010 kolinski stuart Officer Option Execute 12,314 8.50
Feb 2, 2010 kolinski stuart Officer Automatic Sell 6,913 27.16
Jan 27, 2010 kolinski stuart Officer Option Execute 4,359 8.50
Jan 27, 2010 kolinski stuart Officer Automatic Sell 4,359 27.00
Showing 301-320 of 842 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)